Day 1: Tuesday, March 17th, 2026 - EST/EDT (Eastern Daylight, GMT-4)
- Allie Spica - Portfolio Director, Access and Channel, Informa Connect
- Callie Mertel - Portfolio Manager, Access and Channel, Informa Connect
Join Jimmy Choi, Parkinson’s advocate, American Ninja Warrior and global inspiration, as he shares his extraordinary journey of resilience and advocacy. Diagnosed with Young Onset Parkinson’s at 27, Jimmy has defied expectations, completing marathons, breaking records and inspiring millions worldwide. In this keynote, explore the critical themes of patient affordability and access, offering a unique perspective on the challenges faced by patients navigating rare diseases and chronic conditions. Through his personal story, Jimmy highlights the importance of empowering patients, fostering community support and driving innovation in patient support programs.
Embrace possibility in the face of life-altering diagnoses
Champion access, affordability and systemic change
Build solutions through partnerships in healthcare
Redefine what’s possible for patients and caregivers
- Jimmy Choi - Endurance Athlete, 3-time World Record Holder, Parkinson’s Advocate
What are patients with chronic conditions experiencing when it comes to affordability and access? This session shares new national-level research capturing the perspectives of thousands of individuals with chronic illnesses. Explore the latest insights into how financial pressures and healthcare policy reforms are shaping the future of patient access and affordability.
- Amy Niles - Chief Mission Officer, PAN Foundation
- George Valentine - Patient Advocate, PAN Foundation Patient & Family Advisory Council Member
- Kevin Kristy Aloysius - Director of Pharmacy Operations, Legacy Community Health
- Sharon S. Gentry, MSN, RN, AOCN, HON-ONN-CG - Advisor, Academy of Oncology Nurse & Patient Navigator (AONN+)
The chaos of the healthcare landscape is driving the need to prepare for a future marked by greater access challenges, exacerbated affordability concerns, and an overwhelming availability of technological solutions. In this session, we will tackle the impact of the trends below on your patient populations and the delivery of patient support.
Gauging the impact of landmark policy changes (One Big Beautiful Bill, ACA enhanced subsidies, etc.) on patient access to affordable healthcare and medications
Assessing how the national AI framework will shape utilization of digital and AI solutions
Deciphering how payer policies and policy decisions will introduce new pain points within the patient experience
Building a strategic framework to best future-proof your patient support program
Whether we’re ready or not, the challenging landscape continues to radically shift. Become better prepared to support your patients in 2026 and beyond.
- Corey Ford - Principal, Nuvera, an Inizio Engage Company
In this exclusive roundtable, industry leaders will dive deep into how patient access needs are being assessed and the critical role affordability plays in shaping healthcare decisions. With a focus on real-world strategies and emerging trends, explore how data-driven insights are informing policy, operational changes, and innovative approaches to patient support.
- Joanna Stevens - Vice President of Enterprise Strategy and Solutions, Cencora
- Geoff Fisher - Senior Director, Patient Access Programs Foundation, Patient Assistance Programs, GSK
- Wael Alkhalil - Head of Patient Access, Brand Strategy & Operations - Plasma Derived Therapies, Takeda
- Diana Basamula - Associate Director, Patient Affordability Programs, Sanofi
- Tiffany Patrick - Chief Patient Officer, Amicus Therapeutics
Understand how federal policy changes—both legislative and regulatory—will continue to shape the healthcare landscape, focusing on the One Big Beautiful Bill Act, Inflation Reduction Act, Most Favored Nation, PBM reform, and more
Gain insight into how these policy changes will affect patient access and your patient support programs
Review a roadmap for how your patient support program should plan for these major changes and incorporate these trends in your strategic planning
- Max Bronstein - CEO, Aviva Strategies
- Anthony Mitchell - Vice President, Federal Affairs, AHIP
- Chris Jones - Director, Federal Government Relations, Biotechnology Innovation Organization (BIO)
- Joel White - President, Horizon Government Affairs
Join senior leaders for a candid discussion on industry challenges, from budget constraints to organizational changes. This session addresses how to make strategic decisions in an evolving healthcare landscape.
Respond to industry consolidation and its impact on patient services programs
Adapt to changing employee skill requirements as digital transformation reshapes patient support
Develop strategies for resource optimization to remain innovative in a neutral, stagnant market
Strategize on the increased complexity in the PA process
- Chris Dowd - Senior Vice President, ConnectiveRx
- Rhonda Hughes - Head of Patient Services, Biogen
- Todd Hudson - Vice President, Access, Trade & Patient Services, Pharvaris
- Joanne de Vries - Vice President & Head of Patient Services, Rare Blood Disorders & Oncology, Sanofi
This forward-thinking session examines artificial intelligence not merely as a technological trend but as a strategic tool that can transform patient support programs when implemented with purpose and vision.
Evolve your support program beyond tactical intervention into AI-driven patient experience design
Use gen AI as a care partner by optimizing routine tasks and preserving high-touch human interactions for the moments that matter most
Establish meaningful metrics for measuring AI's impact on patient support strategies including prior authorization success, adherence and patient satisfaction
- Michelle Kelts - Senior Director, Strategic Operations, Patient Support Services, IQVIA
- Joe Carroll - Director, Data Management, IQVIA
- Sudha Ragothaman - Director, Data and Analytics, Patient Support Services, IQVIA
Examine different models for structuring field access teams to support reimbursement and access. Learn how to deploy field teams effectively based on therapeutic area needs and market dynamics.
Compare field team models from full-service field reimbursement managers to specialized roles
Identify the optimal deployment method for your specific product and market needs
Establish meaningful KPIs to measure field team effectiveness and value
Balance proactive and reactive engagement strategies for maximum field impact
- Kimberly Howard - Senior Manager, Field Reimbursement Services, CoverMyMeds
- Richard Fessler - Vice President, Product Portfolio Management, CoverMyMeds
This session examines the industry’s newest access model, direct-to-patient (DTP). Understand how external market forces, such as executive-level policy pressures and consumer demand for self-serve experiences, are influencing DTP model adoption, as well as and how DTP models should be leveraged as part of a broader access strategy.
Review market influences on DTP adoption and understand how to evaluate whether this model aligns to your organization’s strategic objectives.
Understand the key considerations for launching a DTP access model and its advantages and disadvantages.
Examine how DTP models can be tailored to best support your end-users – patients, healthcare providers and pharmacies – to deliver optimal experiences.
Learn how to evaluate your DTP vendor with intention and identify a partner who can evolve with your DTP strategy.
- Jordan Armstrong - Vice Preisdent, Business Development, AssistRx
- Brok Vandersteen - Vice President, Business Development, AssistRx
The future of patient support depends not just on adopting AI but on adopting it wisely. During this session, explore what it takes for pharma organizations to move beyond the hype of automation and into true AI maturity. Drawing from real-world partnerships and use cases, learn how intelligent systems can elevate (not replace) human expertise in patient services. Attendees will learn how to assess their organization’s AI maturity, build cross-functional collaboration and ensure their investments in technology drive measurable improvements in patient experience and outcomes.
Define AI maturity and learn how to map your organization’s current stage
Identify common pitfalls that cause AI projects to fail and how to avoid them
Discover how AI can strengthen human empathy and insight in patient support
- Amy Brown - CEO and Founder, Authenticx
